This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
Journal of Experimental & Clinical Cancer Research Open Access 02 September 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
30 November 2018
In the version of this article initially published, Table 1 listed SM04554 as a Wnt pathway inhibitor; in fact, it is a Wnt pathway activator. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Wnt is back in drugmakers' sights, but is it druggable?. Nat Biotechnol 36, 1028–1029 (2018). https://doi.org/10.1038/nbt1118-1028
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1118-1028
This article is cited by
-
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway
Journal of Experimental & Clinical Cancer Research (2022)